Search
for
Sort by
Research 331–360 of 1000+
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction
- Aromatic plants as cosmeceuticals: benefits and applications for skin health
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Effect of diode pumping solid state laser with wavelength 589 nm on gene expression of interlukine-2 and interferon-gamma Lowercase in human T-lymphocytes
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Analysis of histology and long noncoding RNAs involved in the rabbit hair follicle density using RNA sequencing
- Fast clinical response with topical ruxolitinib in the management of non-segmental vitiligo detected by VISIA<sup>®</sup> analysis system
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies
- New therapies for alopecia areata
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Epigenetic regulation in adult stem cells and cancers
- Humanized CXCL12 antibody delays onset and modulates immune response in alopecia areata mice: insights from single-cell RNA sequencing
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Therapeutic Burden as Predictor of Response to Baricitinib for Alopecia Areata in Real Life: Prospective Study
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Elevation of circulating DNAs of disease-associated cytokines in serum cell-free DNA from patients with alopecia areata
- Retrospective Analysis of Oral Tofacitinib Treatment for Alopecia Areata at a Tertiary Care Hospital in Saudi Arabia
- Ottawa, Ontario, Canada, February 13–16, 2013